489 related articles for article (PubMed ID: 1375700)
21. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
Nichols GE; Normansell DE; Williams ME
Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
[TBL] [Abstract][Full Text] [Related]
22. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
[TBL] [Abstract][Full Text] [Related]
23. Regulation of CD3- lymphocyte function with an antibody against the IL-2 beta chain receptor: modulation of NK and LAK activity and production of IFN gamma.
Ortaldo JR; Frey J; Takeshita T; Sugamura K
Eur Cytokine Netw; 1990; 1(1):27-34. PubMed ID: 2151685
[TBL] [Abstract][Full Text] [Related]
24. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
25. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
[TBL] [Abstract][Full Text] [Related]
26. Clonal analysis of human CD4-CD8-CD3- thymocytes highly purified from postnatal thymus.
Hori T; Spits H
J Immunol; 1991 Apr; 146(7):2116-21. PubMed ID: 1826017
[TBL] [Abstract][Full Text] [Related]
27. Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy.
Antonaci S; Polignano A; Ottolenghi A; Tortorella C; Schena FP
Cytobios; 1992; 69(276):27-34. PubMed ID: 1374697
[TBL] [Abstract][Full Text] [Related]
28. [Characterization of peripheral blood natural killer (NK) cells in two patients with CD16+ CD56- NK cell-lineage granular lymphocyte-proliferative disorder].
Egashira M; Kaneko T; Oshimi K; Mizoguchi H; Ishida M
Rinsho Ketsueki; 1995 Feb; 36(2):69-75. PubMed ID: 7536278
[TBL] [Abstract][Full Text] [Related]
29. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
Heiskala M; Ståhls A; Seppälä I; Timonen T
Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
[TBL] [Abstract][Full Text] [Related]
30. Differential oncolytic effect of NK-enriched subsets in long-term interleukin-2 cultures.
Fuchshuber PR; Lotzová E
Lymphokine Cytokine Res; 1992 Oct; 11(5):271-6. PubMed ID: 1281676
[TBL] [Abstract][Full Text] [Related]
31. Appearance and phenotypic characterization of circulating Leu 19+ cells in cancer patients receiving recombinant interleukin 2.
Ellis TM; Creekmore SP; McMannis JD; Braun DP; Harris JA; Fisher RI
Cancer Res; 1988 Nov; 48(22):6597-602. PubMed ID: 2902918
[TBL] [Abstract][Full Text] [Related]
32. CD3 negative "small agranular lymphocytes" are natural killer cells.
Inverardi L; Witson JC; Fuad SA; Winkler-Pickett RT; Ortaldo JR; Bach FH
J Immunol; 1991 Jun; 146(11):4048-52. PubMed ID: 1827820
[TBL] [Abstract][Full Text] [Related]
33. Lymphoproliferative disorder of granular lymphocytes. A heterogeneous disease.
McDaniel HL; MacPherson BR; Tindle BH; Lunde JH
Arch Pathol Lab Med; 1992 Mar; 116(3):242-8. PubMed ID: 1371379
[TBL] [Abstract][Full Text] [Related]
34. Lymphoproliferative disorder of granular lymphocytes. More questions than answers.
McKenna RW
Arch Pathol Lab Med; 1992 Mar; 116(3):235-7. PubMed ID: 1371378
[No Abstract] [Full Text] [Related]
35. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.
Keever CA; Pekle K; Gazzola MV; Collins NH; Gillio A
Cell Immunol; 1990 Mar; 126(1):211-26. PubMed ID: 1689220
[TBL] [Abstract][Full Text] [Related]
36. A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.
Moretta A; Tambussi G; Bottino C; Tripodi G; Merli A; Ciccone E; Pantaleo G; Moretta L
J Exp Med; 1990 Mar; 171(3):695-714. PubMed ID: 2137855
[TBL] [Abstract][Full Text] [Related]
37. Generation of a lipid-like cytotoxin from human CD16+ natural killer cells.
Cosentino LM; Cathcart MK
Cancer Res; 1989 Dec; 49(23):6662-9. PubMed ID: 2531033
[TBL] [Abstract][Full Text] [Related]
38. CD8+CD11b+ peripheral blood T lymphocytes contain lymphokine-activated killer cell precursors.
Dianzani U; Zarcone D; Pistoia V; Grossi CE; Pileri A; Massaia M; Ferrarini M
Eur J Immunol; 1989 Jun; 19(6):1037-44. PubMed ID: 2502419
[TBL] [Abstract][Full Text] [Related]
39. CD3/Ti gamma A: a functional gamma-receptor complex expressed on human peripheral lymphocytes.
Faure F; Jitsukawa S; Triebel F; Hercend T
J Immunol; 1988 Mar; 140(5):1372-9. PubMed ID: 2964471
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: the FcR gamma III (CD16) molecule and NK cell differentiation.
Warren HS; Skipsey LJ
Immunology; 1991 Jan; 72(1):150-7. PubMed ID: 1825480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
